MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology
Study ID
NCT06555952
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • MegaNatural-BP SR 150Mg Tablet — DIETARY_SUPPLEMENT
    GSE MegaNatural BP
  • Placebo Capsule — OTHER
    given in place of GSE MegaNatural BP

Study Details

Inflammation and stressors can interfere with the function of the lining of blood vessels and insulin activity, therefore, investigators are aiming to see how the Grape seed Extract (GSE) called MegaNatural BP can help with limiting the effects of these factors. This research will study the effects of taking 150mg of MegaNatural BP GSE per day on blood pressure levels along with influences on heart health through assessing the function of the blood vessel lining and levels of inflammation.

Key Dates

Start date
Aug 8, 2024
Status verified
Jul 2025
Primary completion
Jul 22, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: GSE Capsule
    150mg Grapeseed Extract MegaNatural BP
  • Placebo Comparator: Placebo Capsule
    Placebo supplement in place of GSE capsule

Primary Outcome Measure

Difference in change of systolic blood pressure [ Time Frame: 6 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Clinical Nutrition Research CenterChicagoIllinois60616
freemanstudies
[email protected]
312-567-5300

Find similar trials in Chicago, IL

By condition
Hypertension (high blood pressure)
By specialty
CardiologyHeart disease
By research site
Clinical Nutrition Research Center· Chicago, IL

Related Studies